The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei

Neuropathology and Applied Neurobiology

Volumn 26, Issue 6, 2000, Pages 553-567

  Rüb, Udo ^a   Del Tredici, K ^a   Schultz, C ^a   Thal, D R ^a   Braak, E ^a   Braak, H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Brainstem; Cytoskeleton; Neurofibrillary changes; Staging; Tau protein

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN STEM; CADAVER; CLINICAL ARTICLE; COGNITION; CYTOSKELETON; DISEASE COURSE; DORSAL RAPHE NUCLEUS; EMOTIONAL DEPRIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAPHE NUCLEUS; SEROTONINERGIC SYSTEM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; CEREBRAL CORTEX; CYTOSKELETON; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEUROFIBRILLARY TANGLES; NEUROPIL; RAPHE NUCLEI;

EID: 0034527347     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2000.00291.x     Document Type: Article

References (61)

1. Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease
2. Cell loss in the nucleus raphes dorsalis in Alzheimer's disease
3. Subcortical afferents to the hippocampal formation in the monkey
4. Awakening the sleeping giant: Anatomy and plasticity of the brain serotoninergic system
5. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus
6. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease
7. Personality changes in Alzheimer's disease
8. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
9. Über die Kerngebiete des menschlichen Hirnstammes. II. Díe Raphekerne
10. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
11. Neuropathological stageing of Alzheimer-related changes
12. Staging of Alzheimer's disease-related neurofibrillary changes
13. Frequency of stages of Alzheimer-related lesions in different age categories
14. A case-control study of Alzheimer's disease in Australia
15. Monoaminergic innervation of cingulate cortex
16. Cortical neurochemistry in Alzheimer-type dementia
17. Nucleus raphe dorsalis in dementia of Alzheimer type: Neurofibrillary changes and neuronal packing density
18. The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and a model system
19. Diagnosis and staging of Alzheimer's disease
20. The basis for behavioural disturbances in dementia
21. The experience and expression of pain in Alzheimer patients
22. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
23. Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex
24. Tau protein and the neurofibrillary pathology of Alzheimer's disease
25. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
26. Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's disease
27. Role of medulla oblongata in generation of sympathetic and vagal outflows
28. Brain stem serotonin-synthesizing neurons in Alzheimer's disease: A clinicopathological correlation
29. Clinical significance of sleep-disordered breathing in Alzheimer's disease. Preliminary data
30. Descending motor pathways and the spinal motor system: Limbic and non-limbic components
31. The natural history of Alzheimer neurofibrillary tangles and amyloid deposits
32. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia
33. The entorhinal cortex of the monkey: III. Subcortical afferents
34. Silver labeling of Alzheimer neurofibrillary changes and brain β-amyloid
35. Cognitive, emotional and behavioral dysfunctions in aging and dementia
36. Clinical risk factors for Alzheimer's disease: A population-based case-control study
37. Tau protein and Alzheimer disease
38. Monoclonal antibodies with selective specifity for Alzheimer tau are directed against phosphatase-sensitive epitopes
39. The greater limbic system, the emotional motor system and the brain
40. The human oral raphe system
41. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease related neurofibrillary changes
42. Monoamine neurons in aging and ALzheimer's disease
43. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease
44. Personality alterations in dementia of the Alzheimer type
45. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of hrp
46. Neuropathology of Alzheimer's disease and animal models
47. Sleep in the dementing disorders
48. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease
49. Distinct nuclear groups in the lower brainstem consistently develop Alzheimer's disease-associated neurofibrillary changes
50. Axonal and transneuronal transport in the transmission of neurological disease: Potential role in system degenerations, including Alzheimer's disease
51. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert
52. Polyethylene glycol embedding: A technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining
53. A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease
54. Raphe nuclei and the serotoninergic system
55. Indoleamines in depression and suicide
56. Autonomic dysfunction in patients with dementia of the Alzheimer type
57. Anatomy and physiology of descending control of nociceptive responses of dorsal horn neurons: Comprehensive review
58. Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons
59. The neuopathology of aminergic nuclei in Alzheimer's disease